ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,522Medicare Part D Prescriptions Filled, Including Refills

Rank: 128 out of 761

$440K Total Retail Price of All Prescriptions

Rank: 171 out of 761

335 Patients Receiving at Least One Drug in Part D
92%Patients 65 Years and Older
31% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Oregon
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 335 patients filled at least one prescription for a schedule two drug, compared to an average of 9%.

Schedule Three
Controlled Substances

19% of this provider’s 335 patients filled at least one prescription for a schedule three drug, compared to an average of 13%.

Risky Drugs to Seniors

2% of this provider’s 8,737 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$46 was the average price of a prescription from this provider, compared to $54 among peers.

Prescriptions per Patient

28 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Oregon
LISINOPRIL 407 387 1 1
SIMVASTATIN 328 320 2 2
OMEPRAZOLE 313 302 3 4
AMLODIPINE BESYLATE 300 283 4 6
LEVOTHYROXINE SODIUM 297 292 5 3
LOSARTAN POTASSIUM 287 284 6 13
FUROSEMIDE 274 260 7 7
HYDROCODONE-ACETAMINOPHEN 242 195 S3 8 5
ATENOLOL 242 228 8 8
METOPROLOL SUCCINATE 227 203 10 16
ATORVASTATIN CALCIUM 194 181 11 12
METFORMIN HCL ER 191 171 12 67
POTASSIUM CHLORIDE 184 184 13 18
DIGOXIN 154 154 14 43
HYDROCHLOROTHIAZIDE 146 132 15 11
TRAZODONE HCL 137 133 16 23
TERAZOSIN HCL 120 120 17 86
GABAPENTIN 119 104 18 15
SERTRALINE HCL 115 115 19 25
PREDNISONE 89 82 20 30
ALLOPURINOL 82 81 21 28
PRAVASTATIN SODIUM 82 56 21 20
KLOR-CON 10 81 81 23 74
GEMFIBROZIL 81 70 23 116
METFORMIN HCL 79 75 25 10
BENICAR 79 79 25 81
ALENDRONATE SODIUM 79 79 25 21
DILTIAZEM 24HR ER 79 78 25 190
WARFARIN SODIUM 78 74 29 9
SPIRONOLACTONE 70 52 30 45
FLUOXETINE HCL 69 64 31 31
COMBIVENT 69 37 31 110
KLOR-CON M20 69 69 31 99
TRAMADOL HCL 69 69 31 34
AMITRIPTYLINE HCL 65 62 R 35 54
DILTIAZEM ER 63 55 36 130
METOPROLOL TARTRATE 62 62 37 14
CRESTOR 60 59 38 36
NAMENDA 59 59 39 59
GLYBURIDE 59 54 R 39 77
LISINOPRIL-HYDROCHLOROTHIAZIDE 58 56 41 35
LOVASTATIN 55 51 42 17
LOSARTAN-HYDROCHLOROTHIAZIDE 54 42 43 65
ENALAPRIL MALEATE 52 40 44 71
DOXAZOSIN MESYLATE 50 50 45 55
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 4, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.